1st Quarter - Report

THE NICKLES GROUP, LLC for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: SENATE

Budget/Appropriations BUD

H.R.6074, Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations, provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: SENATE

Bills named: H.R. 6074 (116th), S. 3548 (116th)

Defense DEF

NDAA - provisions related to biological and chemical defense.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: SENATE

Disaster Planning/Emergencies DIS

Monitored issues related to the material threat list.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.